A detailed history of Wells Fargo & Company transactions in Fonar Corp stock. As of the latest transaction made, Wells Fargo & Company holds 14 shares of FONR stock, worth $214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$214
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.39 - $20.42 $604 - $857
-42 Reduced 75.0%
14 $0
Q4 2023

Feb 09, 2024

BUY
$12.52 - $20.5 $25 - $41
2 Added 3.7%
56 $1,000
Q3 2023

Nov 13, 2023

BUY
$15.4 - $17.47 $46 - $52
3 Added 5.88%
54 $0
Q2 2023

Aug 15, 2023

BUY
$15.27 - $17.94 $45 - $53
3 Added 6.25%
51 $0
Q1 2023

May 12, 2023

BUY
$15.4 - $18.75 $92 - $112
6 Added 14.29%
48 $0
Q4 2022

Feb 13, 2023

SELL
$14.95 - $18.82 $598 - $752
-40 Reduced 48.78%
42 $0
Q3 2022

Nov 14, 2022

SELL
$13.31 - $15.36 $53 - $61
-4 Reduced 4.65%
82 $2,000
Q2 2022

Aug 12, 2022

BUY
$15.19 - $19.05 $75 - $95
5 Added 6.17%
86 $2,000
Q4 2021

Feb 14, 2022

SELL
$14.55 - $18.6 $1,091 - $1,395
-75 Reduced 48.08%
81 $2,000
Q3 2021

Nov 15, 2021

BUY
$15.44 - $17.77 $1,127 - $1,297
73 Added 87.95%
156 $3,000
Q2 2021

Aug 16, 2021

SELL
$16.58 - $19.0 $856,572 - $981,597
-51,663 Reduced 99.84%
83 $2,000
Q1 2021

May 13, 2021

BUY
$17.74 - $20.35 $610,557 - $700,385
34,417 Added 198.61%
51,746 $936,000
Q4 2020

Feb 09, 2021

BUY
$17.06 - $22.15 $12,283 - $15,947
720 Added 4.33%
17,329 $301,000
Q3 2020

Nov 05, 2020

BUY
$20.71 - $26.49 $88,680 - $113,430
4,282 Added 34.74%
16,609 $347,000
Q2 2020

Aug 13, 2020

BUY
$14.18 - $25.49 $41,277 - $74,201
2,911 Added 30.92%
12,327 $263,000
Q1 2020

May 14, 2020

BUY
$11.21 - $21.54 $105,553 - $202,820
9,416 New
9,416 $137,000

Others Institutions Holding FONR

About FONAR CORP


  • Ticker FONR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 6,554,210
  • Market Cap $100M
  • Description
  • FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic servi...
More about FONR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.